Skip to main content

Table 3 Angiographic characteristics of CAD patients

From: The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events

Variable PlA1 (n = 300) PlA2 (n = 100) p Value
Coronary artery disease (%)    
LAD 61.9 50 0.27
Cx 33.6 29 0.37
Dx 45 50 0.30
Multivessel Disease (%) 28 30 0.49
Lesion type, B2/C (%) 78 85 0.55
BMS (%) 74 66 0.56
DES (%) 26 34 0.57
TIMI 3 post PCI (%) 97.5 98 0.89
cTFC post (mean ± SD) 15.10 ± 6 14.25 ± 8 0.76
Lesion length (mm) 15.54 ± 6.59 16.48 ± 8.74 0.13
Preprocedural stenosis (%) 86.55 ± 10.19 85.05 ± 11.48 0.11
Stent/patient (n) 1.08 ± 0.32 1.07 ± 0.26 0.74
  1. BMS: Bare metal stent, Cx: Left circumflex coronary artery, DES: Drug eluting stent, Dx: Right coronary artery, LAD: Left anterior descending coronary artery.